Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Psychiatric Quarterly
Published in: Psychiatric Quarterly 3/2012

01-09-2012 | Original Paper

Borderline Personality Disorder and Depression: An Update

Authors: Maria Luca, Antonina Luca, Carmela Calandra

Published in: Psychiatric Quarterly | Issue 3/2012

Login to get access

Abstract

To review the literature related to recent temperamental and biological findings on borderline personality disorder (BPD) and major depression, the close link between the two disorders, and the latest therapeutical findings on BPD, focusing on the conditions of co-morbidity between depression and BPD. The National Institutes of Health’s PubMed database was used to identify indexed studies on BPD, depression and the co-morbidity between the two. Only studies published between 2000 and 2011 were assessed. Similar temperamental features have been demonstrated in BPD and depression. The strong link between the two disorders seems to be widely recognized by scientific community. Psychotherapy and new antipsychotics are the topics of current major interest of research. The therapeutic targets in the case of co-morbidity are BPD features associated with depressive symptoms, thus influencing prognosis. A global assessment is, in fact, fundamental for a successful therapy for the treatment of the several aspects of a complex psychopathological phenomenon.
Literature
1.
Grant BF, Chou SP, Goldstein RB, et al.: Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 69:533–545, 2008.PubMedCrossRef
2.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders Text Revision (DSM IV-TR) 4th edn. Washington, DC, 2000.
3.
Sansone RA, Sansone LA: Emotional hyper-reactivity in borderline personality disorder. Psychiatry(Edgmont) 7:16–20, 2010.
4.
Bolton JM, Robinson J: Population-attributable fractions of axis I and Axis II mental disorders for suicide attempts: findings from a representative sample of the adult, noninstitutionalized US population. American Journal of Public Health 100:2473–2480, 2010.PubMedCrossRef
5.
Yen S, Shea MT, Sanislow CA, et al.: Borderline personality disorder criteria associated with prospectively observed suicidal behavior. The American Journal of Psychiatry 161:1296–1298, 2004.PubMedCrossRef
6.
Javdani S, Sadeh N, Verona E: Suicidality as a function of impulsivity, callous-unemotional traits, and depressive symptoms in youth. Journal of Abnormal Psychology, 120:400–413, 2011.PubMedCrossRef
7.
Rihmer Z, Benazzi F: Impact on suicidality of the borderline personality traits impulsivity and affective instability. Annals of Clinical Psychiatry 22:121–128, 2010.PubMed
8.
Watkins ER: Depressive rumination and co-morbidity. Evidence for brooding as a transdiagnostic process. Journal of Rational-Emotive & Cognitive Behavior Therapy 27:160–175, 2009.CrossRef
9.
Muralidharan A, Sheets ES, Madsen J, et al.: Interpersonal competence across domains: relevance to personality pathology. Journal of Personality Disorders 25:16–27, 2011.PubMedCrossRef
10.
Joyce PR, Mulder RT, Luty SE, et al.: Borderline personality disorder in major depression: symptomatology, temperament, character, differential drug response, and 6-month outcome. Comprehensive Psychiatry 44:35–43, 2003.PubMedCrossRef
11.
Eaton NR, Krueger RF, Keyes KM, et al.: Borderline personality disorder co-morbidity: relationship to the internalizing-externalizing structure of common mental disorders. Psychological Medicine 41:1041–1050, 2011.PubMedCrossRef
12.
Kampman O, Poutanen O: Can onset and recovery in depression be predicted by temperament? A systematic review and meta-analysis. Journal of Affective Disorders (2011 in press).
13.
Celikel FC, Kose S, Cumurcu BE, et al.: Cloninger’s temperament and character dimensions of personality in patients with major depressive disorder. Comprehensive Psychiatry 50:556–561, 2009.PubMedCrossRef
14.
Arkar H, Sorias O, Tunca Z, et al.: Factorial structure, validity, and reliability of the Turkish temperament and character inventory. Turkish journal of Psychiatry 16:190–204, 2005.PubMed
15.
Fossati A, Donati D, Donini M, et al.: Temperament, character, and attachment patterns in borderline personality disorder. Journal of Personality Disorders 15:390–402, 2001.PubMedCrossRef
16.
Chapman AL, Specht MV, Cellucci T: Borderline personality disorder and deliberate self-harm: does experiental avoidance play a role? Suicide and Life-Threatening Behavior 35:388–399, 2005.PubMedCrossRef
17.
Quilty LC, Godfrey KM, Kennedy SH, et al.: Harm avoidance as a mediator of treatment response to antidepressant treatment of patients with major depression. Psychotherapy and Psychosomatics 79:116–122, 2010.PubMedCrossRef
18.
Skodol AE, Grilo CM, Pagano ME, et al.: Effects of personality disorders on functioning and well-being in major depressive disorder. Journal of Psychiatric Practice 11:363–368, 2005.PubMedCrossRef
19.
Gunderson JG, Stout RL, Sanislow CA, et al.: New episodes and new onsets of major depression in borderline and other personality disorders. Journal of Affective Disorders 111:40–45, 2008.PubMedCrossRef
20.
Grilo CM, Stout RL, Markowitz JC, et al.: Personality disorders predict relapse after remission from an episode of major depressive disorder: a 6-year prospective study. Journal of Clinical Psychiatry 71:1629–1635, 2010.PubMedCrossRef
21.
Zanarini MC, Laudate CS, Frankenburg FR, et al.: Predictors of self-mutilation in patients with borderline personality disorder: a 10-year follow-up study. Journal of Psychiatric Research 45:823–828, 2011.PubMedCrossRef
22.
Joyce PR, McKenzie JM, Luty SE, et al.: Temperament, childhood environment and psychopathology as risk factors for avoidant and borderline personality disorders. Australian and New Zealand Journal of Psychiatry 37:756–764, 2003.PubMed
23.
Nilsson AK, Jørgensen CR, Straarup KN, et al.: Severity of affective temperament and maladaptive self-schemas differentiate borderline patients, bipolar patients, and controls. Comprehensive Psychiatry 51:486–491, 2010.PubMedCrossRef
24.
Hopwood CJ, Donnellan MB, Zanarini MC: Temperamental and acute symptoms of borderline personality disorder: associations with normal personality traits and dynamic relations over time. Psychological Medicine 40:1871–1878, 2010.PubMedCrossRef
25.
Brühl AB, Viebke MC, Baumgartner T, et al.: Neural correlates of personality dimensions and affective measures during the anticipation of emotional stimuli. Brain Imaging and Behavior 5:86–96, 2011.PubMedCrossRef
26.
Preißler S, Dziobek I, Ritter K, et al.: Social cognition in borderline personality disorder: evidence for disturbed recognition of the emotions, thoughts, and intentions of others. Frontiers in Behavioral Neuroscience 4:182, 2010.
27.
Gunderson JG: Disturbed relationships as a phenotype for borderline personality disorder. The American Journal of Psychiatry 164:1637–1640, 2007.PubMedCrossRef
28.
Morse JQ, Hill J, Pilkonis PA, et al.: Anger, preoccupied attachment, and domain disorganization in borderline personality disorder. Journal of Personality Disorders 23:240–257, 2009.PubMedCrossRef
29.
Zanarini MC, Frankenburg FR, Yong L, et al.: Borderline psychopathology in the first-degree relatives of borderline and axis II comparison probands. Journal of Personality Disorders 18:439–447, 2004.PubMedCrossRef
30.
Barnow S, Spitzer C, Grabe HJ, et al.: Individual characteristics, familial experience and psychopathology in children of mothers with borderline personality disorder. Journal of the American Academy of Child and Adolescent Psychiatry 45:965–972, 2006.PubMedCrossRef
31.
Igarashi H, Hasui C, Uji M, et al.: Effects of child abuse history on borderline personality traits, negative life events, and depression: a study among a university student population in Japan. Psychiatry Research 180:120–125, 2010.PubMedCrossRef
32.
Galione J, Zimmerman M: A comparison of depressed patients with and without borderline personality disorder: implications for interpreting studies of the validity of the bipolar spectrum. Journal of Personality Disorders 24:763–772, 2010.PubMedCrossRef
33.
Skodol AE, Grilo CM, Keyes KM, et al.: Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. The American Journal of Psychiatry 168:257–264, 2011.PubMedCrossRef
34.
Mezulis AH, Priess HA, Hyde JS: Rumination mediates the relationship between infant temperament and adolescent depressive symptoms. Depression Research and Treatment 2011:487873.
35.
De Bolle M, De Fruyt F, Quilty LC, et al.: Does personality disorder co-morbidity impact treatment outcome for patients with major depression?: A multi-level analysis. Journal of Personality Disorders 25:1–15, 2011.PubMedCrossRef
36.
Borecki L, Gozdzik-Zelazny A, Pokorski M: Personality and perception of stigma in psychiatric patients with depressive disorders. European Journal of Medical Research 15(Suppl 2):10–16, 2010.PubMed
37.
Spittlehouse JK, Pearson JF, Luty SE, et al.: Measures of temperament and character are differentially impacted on by depression severity. Journal of Affect Disorders 126:140–146, 2010.CrossRef
38.
Mauchnik J, Schmahl C: The Latest neuroimaging findings in borderline personality disorder. Current Psychiatry Reports 12:46–55, 2010.PubMedCrossRef
39.
Prossin AR, Love TM, Koeppe RA, et al.: Dysregulation of regional endogenous opioid function in borderline personality disorder. The American Journal of Psychiatry 167:925–933, 2010.PubMedCrossRef
40.
Röder CH, Michal M, Overbeck G, et al.: Pain response in depersonalization: a functional imaging study using hypnosis in healthy subjects. Psychotherapy and Psychosomatics 76:115–121, 2007.PubMedCrossRef
41.
Schmahl C, Bohus M, Esposito F, et al.: Neural correlates of antinociception in borderline personality disorder. Archives of General Psychiatry 63:659–667, 2006.PubMedCrossRef
42.
Kraus A, Valerius G, Seifritz E, et al.: Script-driven imagery of self-injurious behavior in patients with borderline personality disorder: a pilot FMRI study. Acta Psychiatrica Scandinavica 121:41–51, 2010.PubMedCrossRef
43.
King-Casas B, Sharp C, Lomax-Bream L, et al.: The rupture and repair of cooperation in borderline personality disorder. Science 321:806–810, 2008.PubMedCrossRef
44.
Sala M, Caverzasi E, Lazzaretti M, et al.: Dorsolateral prefrontal cortex and hippocampus sustain impulsivity and aggressiveness in borderline personality disorder. Journal of Affective Disorders 131:417–421, 2011.PubMedCrossRef
45.
Oquendo MA, Krunic A, Parsey RV, et al.: Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder. Neuropsychopharmacology 30:1163–1172, 2005.PubMedCrossRef
46.
Nemoda Z, Lyons-Ruth K, Szekely A, et al.: Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients. Behavioral and Brain Functions 6:4, 2010.PubMedCrossRef
47.
Joyce PR, McHugh PC, McKenzie JM, et al.: A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients. Psychological Medicine 36:807–813, 2006.PubMedCrossRef
48.
Lieb K, Völlm B, Rücker G, et al.: Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. The British Journal of Psychiatry 196:4–12, 2010.PubMedCrossRef
49.
American Psychiatric Association Practice Guidelines: Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. The American Journal of Psychiatry 158(Suppl 10):1–52, 2001.
50.
Rinne T, van den Brink W, Wouters L, et al.: SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. The American Journal of Psychiatry 159:2048–2054, 2002.PubMedCrossRef
51.
Bellino S, Rinaldi C, Bogetto F: Adaptation of interpersonal psychotherapy to borderline personality disorder: a comparison of combined therapy and single pharmacotherapy. Canadian Journal of Psychiatry 55:74–81, 2010.
52.
Zanarini MC, Frankenburg FR, Parachini EA: A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. Journal of Clinical Psychiatry 65:903–907, 2004.PubMedCrossRef
53.
Silva H, Iturra P, Solari A, et al.: Fluoxetine response in impulsive- aggressive behavior and serotonin transporter polymorphism in personality disorder. Psychiatric Genetics 20:25–30, 2010.PubMedCrossRef
54.
Grootens KP, Verkes RJ: Emerging evidence for the use of atypical antipsychotics in borderline personality disorder. Pharmacopsychiatry 38:20–23, 2005.PubMedCrossRef
55.
Nickel MK, Muehlbacher M, Nickel C, et al.: Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. The American Journal of Psychiatry 163:833–838, 2006.PubMedCrossRef
56.
Schulz SC, Zanarini MC, Bateman A, et al.: Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-bind placebo-controlled study. The British Journal of Psychiatry 193:485–492, 2008.PubMedCrossRef
57.
Soler J, Pascual JC, Campins J, et al.: Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. The American Journal of Psychiatry 162:1221–1224, 2005.PubMedCrossRef
58.
Vohra AK (2010) Treatment of severe borderline personality disorder with clozapine. Indian Journal of Psychiatry 52:267–269.PubMedCrossRef
59.
Weinstein W and Jamison KL: Retrospective case review of lamotrigine use for affective instability of borderline personality disorder. CNS Spectrums 12:207–210, 2007.PubMed
60.
Hollander E, Swann AC, Coccaro EF, et al.: Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. The American Journal of Psychiatry 162:621–624, 2005.PubMedCrossRef
61.
Simeon D, Baker B, Chaplin W, et al.: An Open-label trial of divalproex extended-release in the treatment of borderline personality disorder. CNS Spectrums 12:439–443, 2007.PubMed
62.
Neacsiu D, Rizvi SL, Linehan MM: Dialectical behaviour therapy skills use as a mediator and outcome of treatment for borderline personality disorder. Behaviour Research and Therapy 48:832–839, 2010.PubMedCrossRef
63.
Swenson CR, Sanderson C, Dulit RA, et al.: The application of dialectical behavior therapy for patients with borderline personality disorder on inpatient units. Psychiatric Quarterly 72:307–324, 2001.PubMedCrossRef
64.
McMain SF, Links PS, Gnam WH, et al.: A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. The American Journal of Psychiatry 166:1365–1374, 2010.CrossRef
65.
Brazier J, Tumur I, Holmes M, et al.: Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation. Health Technology Assessment 10:1–117, 2006.PubMed
66.
Simpson EB, Yen S, Costello E, et al.: Combined dialectical behaviour therapy and fluoxetine in the treatment of borderline personality disorder. Journal of Clinical Psychiatry 65:379–385, 2004.PubMedCrossRef
67.
Eizirik M, Fonagy P: Mentalization-based treatment for patients with borderline personality disorder: an overview. Revista Brasileira de Psiquiatria 31:72–75, 2009.PubMedCrossRef
68.
Bellino S, Zizza M, Rinaldi C, et al.: Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapy. Canadian Journal of Psychiatry 51:453–460, 2006.
69.
Bellino S, Zizza M, Rinaldi C, et al.: Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy. Canadian Journal of Psychiatry 52:718–725, 2007.
70.
Prasko J, Brunovsky M, Latalova K, et al.: Augmentation of antidepressants with bright light therapy in patients with comorbid depression and borderline personality disorder. Biomedical Papers of the Medical Faculty of the University Palacky Olomouc Czech Republic 154:355–362, 2010.
71.
Foti ME, Geller J, Guy LS, et al.: Borderline personality disorder: considerations for inclusion in the massachusetts parity list of “biologically-based” disorders. Psychiatric Quarterly 82:95–112, 2011.PubMedCrossRef
72.
Leichsenring F, Leibing E, Kruse J, et al.: Borderline personality disorder. Lancet 377:74–84, 2011.PubMedCrossRef
73.
Hayashi N, Igarashi M, Imai A, et al.: Psychiatric disorders and clinical correlates of suicidal patients admitted to a psychiatric hospital in Tokyo. BMC Psychiatry 10:109, 2010.PubMedCrossRef
Metadata
Title
Borderline Personality Disorder and Depression: An Update
Authors
Maria Luca
Antonina Luca
Carmela Calandra
Publication date
01-09-2012
Publisher
Springer US
Published in
Psychiatric Quarterly / Issue 3/2012
Print ISSN: 0033-2720
Electronic ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-011-9198-7

Other articles of this Issue 3/2012

Psychiatric Quarterly 3/2012 Go to the issue

Original Paper

The Relationship Between Symptomatic Changes and Perceived Improvement Among Patients Treated in Brazilian Community Mental Health Services

Original Paper

Psychiatric Illness and Facebook: A Case Report

Original Paper

Insight in Bipolar Disorder

Original Paper

Factors Involved in Making Decisions to Prescribe Medications for Psychiatric Disorders by Psychiatrists: A Survey Study

Original Paper

Perphenazine Suspension: A New, Old Treatment, Side Effects and Continuous Use

Original Paper

Lamotrigine in the Treatment of Unipolar Depression with and Without Comorbidities: A Literature Review